Researchers now have the tools to analyze the unique metabolic protein signatures of diverse immune cell subpopulations in different states of activation.
Being able to distinguish between different types of macrophages in the brain could shed light on inflammatory diseases such as Alzheimer’s.
New clues into how the immune system remembers a dengue infection may lead to a better vaccine.
Serology testing may be fast and easy to perform, but there are still some limitations that need to be overcome, suggests Laurent Renia.
Clinicians and scientists have discovered a rare mutation that impairs the immune system, and are using their findings to devise treatment strategies
The presence of memory T cells in COVID-19-recovered patients hints at their importance in COVID-19 immunity.
Could there be a drug that can both treat and protect against COVID-19? The answer may be found in antibody drugs, a promising therapeutic modality against the coronavirus.
Two coronavirus experts suggest that the best way to control an outbreak may be to first understand viral biology and behavior in animals and humans.
Scientists at A*STAR have found that a mutation in SARS-CoV-2 called ∆382 leads to milder clinical outcomes, with implications for COVID-19 treatments and vaccines.
Tipped off by artificial intelligence, a research team is testing whether a rheumatoid arthritis drug could be repurposed as a COVID-19 treatment.
Single-cell genomic technology is providing fresh perspectives on the origins of microglia, ancient immune sentinels found in the brain.